NCT01038661 - Tax First-line Chemotherapy With Different Doses and Then Maintenance Therapy | Biotech Hunter

Enrollment

375

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Lung Neoplasms

Interventions

DRUG

Docetaxel

"Formulation: concentrated solution for intravenous infusion (IV)~Route(s) of administration: 1-hour IV"

DRUG

Cisplatin

"Formulation: concentrated solution for intravenous infusion (IV)~Route(s) of administration: 1-3-hour IV"

OTHER

Best supportive care (BSC)

Any treatment including palliative radiotherapy for pain relief-but not chemotherapy - that is considered appropriate by the investigator

Trial Locations (1)

Sanofi-Aventis Administrative Office, Shanghai